Open original FDA record ↗Recall record
- FDA identifier
- Z-1964-2019
- Company in FDA record
- GE Healthcare, LLC
- FDA classification date
- Jul 12, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential for a transducer mis-alignment in certain transvaginal probes.
Source facts
- Action
- GE Healthcare notified customers on about 07/02/2019 via "URGENT MEDICAL DEVICE CORRECTION" letter. Customers were informed that they could continue to use the affected probes, but prior to performing a biopsy, customers should make sure they follow the instructions for safe use in the Basic User Manual to ensure proper device alignment, specifically including the biopsy, biopsy safety and biopsy setup sections. GE Healthcare will correct all affected devices at no cost and a GE Healthcare representative will contact customers to arrange for the correction. Customers were also instructed to complete and return the Medical Device Notification Acknowledgement Response form. Questions or concerns regarding the notification can be directed to GE Healthcare Service at 1-800-437-1171 or your local Service Representative.
- Initiated
- 2019-07-02
- Root cause
- Device Design
- Terminated
- 2020-10-05
- Distribution
- Distribution in the US to Texas. International distribution to France, Greece and Switzerland.
- Recall number
- Z-1964-2019
- Recall status
- Terminated
- CDRH record ID
- 174509
- FDA classified
- 2019-07-12
- Recall event number
- 83271